
Michael Hagensee
Infectious Disease · Louisiana State University School of Medicine in New Orleans Faculty G
Credentials: · ·
History

- 1988–1991
University of Washington Affiliated Hospitals
- 1984–1988
Research
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer
New England Journal of Medicine · 2022 · 396 citations
Journal of Virology · 1993 · First of 3 authors · 330 citations
Clinical Infectious Diseases · 1994 · First of 4 authors · 148 citations

8 papers
- DM
5 papers

5 papers

4 papers

4 papers · 2 as a fellow

4 papers
- PK
4 papers
- RC
4 papers
Grants
- 2024–2029
The Role of Antiretroviral Therapy in Susceptibility to Oral Human Papillomavirus (HPV) Infection
National Institute of Dental and Craniofacial Research · R01
PI · $1.9M · Lsu Health Sciences Center
- 2023–2028
Kaposi Sarcoma in the Era of ART in Africa Program (KEAAP)
National Cancer Institute · U54
Project lead · $334.1K · Lsu Health Sciences Center
- 2013–2019
The Oral Microbiome in HIV-Associated Oral Warts and Candidiasis
National Institute of Dental and Craniofacial Research · R01
PI · $2.8M · Lsu Health Sciences Center
- 2014–2017
Dillard-LSUHSC Minority Health and Health Disparities Research Center
National Institute on Minority Health and Health Disparities · P20
Project lead · $270.4K · Dillard University
Clinical trials
- 2022–2026
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
Principal investigator · Recruiting · Phase 4
Louisiana State University Health Sciences Center in New Orleans
- 2025–2027
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
Site PI · Recruiting
National Cancer Institute (NCI)

